Probiotics and Biomarkers in Irritable Bowel Syndrome

Abroad (travel likely)Recruiting

Conditions

Irritable Bowel Syndrome (IBS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mag-tarmlab, Sahlgrenska University Hospital, Gothenburg, Sweden
MagTarmlab · magtarmlab.se@vgregion.se · +46 31 342 81 07

Study leads

Magnus Simren, MD PHD
Principal Investigator
Göteborg University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

Irritable Bowel Syndrome · Constipation

Abroad (travel likely)RecruitingPHASE2

Mesa, United States · Anaheim, United States

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Irritable Bowel Syndrome

Abroad (travel likely)RecruitingPHASE2

Anniston, United States · Guntersville, United States

Psyllium in Pediatric IBS

Irritable Bowel Syndrome

Abroad (travel likely)RecruitingPHASE2

Durham, United States

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) · Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Abroad (travel likely)Recruiting

Leuven, Belgium · Bobigny, France